Bloodstream infections
Stop bloodstream infections before they start
IV therapy is a critical and fundamental part of patient care. While infusion therapy is a common way to deliver fluids and other types of medications, it comes with risks.
In fact, catheter-associated bloodstream infections (CABSIs) can occur at the time of the initial insertion or anytime throughout the duration of intravenous access — creating the potential for longer hospital stays,1-5 increased care costs2,4 and higher patient mortality.2
Explore our range of solutions to lower your patients’ risk of BSI
From transparent film dressings and strong adhesive fixation dressings to antimicrobial dressings and disinfection caps, our broad portfolio makes it easy for you to select and use the right products for every patient.
Product Resources
Find the right catheter solution for every patient
Patients need to trust that their safety and health are always most important. However, it’s not always easy to tell which catheter is best for every scenario.
We offer three options: antimicrobial solutions, advanced securement dressings and basic protection. Contact your local representative for a free trial, so you can get a feel for how our products can help your patients.
To help you get the best results, we have created a catheter decision guide that matches medical scenarios to the best catheter for the job.
Evidence and guidance
Discover the latest evidence and expert guidance to reduce catheter-related bloodstream infections. Empower your practice with insights and best practices to improve patient outcomes.
Support resources
References:
- Maki, D., and L. Mermel. “Infections Due to Infusion Therapy.” In Hospital Infections, 4th ed., edited by J. V. Bennett and P. S. Brachman, (1998), 689–724. Philadelphia: Lippincott-Raven.
- Signs, CDC Vital. "Making healthcare safer: Reducing bloodstream infections." Morbidity and Mortality Weekly Report 60, no. 8 (2011): 243-248.
- Blot, Stijn I., Pieter Depuydt, Lieven Annemans, Dominique Benoit, Eric Hoste, Jan J. De Waele, Johan Decruyenaere, Dirk Vogelaers, Francis Colardyn, and Koenraad H. Vandewoude. "Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections." Clinical Infectious Diseases 41, no. 11 (2005): 1591-1598.
- Zimlichman, Eyal, Daniel Henderson, Orly Tamir, Calvin Franz, Peter Song, Cyrus K. Yamin, Carol Keohane, Charles R. Denham, and David W. Bates. "Health care–associated infections: a meta-analysis of costs and financial impact on the US health care system." JAMA internal medicine 173, no. 22 (2013): 2039-2046.
- Scheithauer, S., K. Lewalter, J. Schröder, A. Koch, H. Häfner, V. Krizanovic, K. Nowicki, R-D. Hilgers, and S. W. Lemmen. "Reduction of central venous line-associated bloodstream infection rates by using a chlorhexidine-containing dressing." Infection 42, no. 1 (2014): 155-159.
- Timsit, Jean-François, Olivier Mimoz, Bruno Mourvillier, Bertrand Souweine, Maïté Garrouste-Orgeas, Serge Alfandari, Gaétan Plantefeve et al. "Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults." American journal of respiratory and critical care medicine 186, no. 12 (2012): 1272-1278.
- Loveday, H. P., J. A. Wilson, J. Prieto, and M. H. Wilcox. "epic3: revised recommendation for intravenous catheter and catheter site care." Journal of Hospital Infection 92, no. 4 (2016): 346-348.
- "The 3M Tegaderm CHG IV securement dressing for central venous and arterial catheter insertion sites." Medical Technologies Guidance, MTG 25. National Institute for Health and Care Excellence, (2019). https://www.nice.org.uk/guidance/mtg25. Accessed November 25, 2024.